- 首頁
- 科研細胞
- 藥靶模型
-
診斷試劑
腫瘤早篩甲基化標準品
遺傳性基因標準品
優(yōu)生優(yōu)育標準品
HLA標準品
數(shù)字PCR
- 技術(shù)服務(wù)
- 新聞中心
- 資源中心
- 關(guān)于我們
- 聯(lián)系我們
腫瘤早篩甲基化標準品
遺傳性基因標準品
優(yōu)生優(yōu)育標準品
HLA標準品
數(shù)字PCR
診斷試劑
技術(shù)服務(wù)
聯(lián)系我們
藥靶模型
Drug Target Model
CBP73258
I. Introduction | |
Cell Line Name: |
ERBB4 E452K (NRG1b Dependent)/BaF3 |
Host Cell: |
Ba/F3 |
Stability: | 16 passages (in-house test, that not means the cell line will be instable beyond the passages we tested.) |
Freeze Medium: |
90% FBS+10% DMSO |
Complete Culture Medium: |
RPMI-1640+10%FBS+10ng/ml NRG1-beta1 |
Mycoplasma Status: |
Negative |
II. Background | |
Human HER4 kinase, also known as Erb-B4, Proto-Oncogene-Like Protein C-ErbB-4, and Tyrosine Kinase-Type Cell Surface Receptor HER4, GenBank Accession No. NM_005235, a.a. 708-993, with an N-terminal GST-tag, expressed in a Baculovirus infected Sf9 cell expression system. MW=59.5 kDa. |
|
III. Representative Data | |
1.ERBB4 E452K (NRG1b Dependent)/BaF3
|
|
2. Anti-proliferation assay
Figure 2. Anti-proliferation assay of two reference compounds on the ERBB4 E452K (NRG1b Dependent)/BaF3 Stable Cell line. |